1. Academic Validation
  2. Structural and biochemical analysis of atypically low dephosphorylating activity of human dual-specificity phosphatase 28

Structural and biochemical analysis of atypically low dephosphorylating activity of human dual-specificity phosphatase 28

  • PLoS One. 2017 Nov 9;12(11):e0187701. doi: 10.1371/journal.pone.0187701.
Bonsu Ku 1 2 Won Hong 3 Chae Won Keum 1 2 Myeongbin Kim 3 Hyunyeol Ryu 3 Donghwan Jeon 3 Ho-Chul Shin 1 Jae Hoon Kim 4 Seung Jun Kim 1 2 Seong Eon Ryu 3
Affiliations

Affiliations

  • 1 Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
  • 2 Department of Bioscience, University of Science and Technology KRIBB School, Daejeon, Republic of Korea.
  • 3 Department of Bioengineering, College of Engineering, Hanyang University, Seoul, Republic of Korea.
  • 4 Department of Biotechnology, College of Applied Life Science, SARI, Jeju National University, Jeju-do, Republic of Korea.
Abstract

Dual-specificity phosphatases (DUSPs) constitute a subfamily of Protein tyrosine phosphatases, and are intimately involved in the regulation of diverse parameters of cellular signaling and essential biological processes. DUSP28 is one of the DUSP subfamily members that is known to be implicated in the progression of hepatocellular and pancreatic cancers, and its biological functions and enzymatic characteristics are mostly unknown. Herein, we present the crystal structure of human DUSP28 determined to 2.1 Å resolution. DUSP28 adopts a typical DUSP fold, which is composed of a central β-sheet covered by α-helices on both sides and contains a well-ordered activation loop, as do other enzymatically active DUSP proteins. The catalytic pocket of DUSP28, however, appears hardly accessible to a substrate because of the presence of nonconserved bulky residues in the protein tyrosine Phosphatase signature motif. Accordingly, DUSP28 showed an atypically low Phosphatase activity in the biochemical assay, which was remarkably improved by mutations of two nonconserved residues in the activation loop. Overall, this work reports the structural and biochemical basis for understanding a putative oncological therapeutic target, DUSP28, and also provides a unique mechanism for the regulation of enzymatic activity in the DUSP subfamily proteins.

Figures